Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo
- PMID: 21068666
- DOI: 10.1097/ALN.0b013e3181f97fec
Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo
Abstract
Background: Sevoflurane induces preconditioning (SevoPC). The effect of aprotinin and the involvement of endothelial nitric-oxide synthase (NOS) on SevoPC are unknown. We investigated (1) whether SevoPC is strengthened by multiple preconditioning cycles, (2) whether SevoPC is blocked by aprotinin, and (3) whether endothelial NOS plays a crucial role in SevoPC.
Methods: Anesthetized male Wistar rats were randomized to 15 groups (each n = 6) and underwent 25-min regional myocardial ischemia and 2-h reperfusion. Controls were not treated further. Preconditioning groups inhaled 1 minimum alveolar concentration of sevoflurane for 5 min (SEVO-I), twice for 5 min each (SEVO-II), three times for 5 min each (SEVO-III), or six times for 5 min each (SEVO-VI). Aprotinin was administered with and without sevoflurane. Involvement of endothelial NOS was determined with the nonspecific NOS blocker N-nitro-l-arginine-methyl-ester, the specific neuronal NOS blocker 7-nitroindazole, and the specific inducible NOS blocker aminoguanidine.
Results: SevoPC reduced infarct size in all protocols (SEVO-I, 42 ± 6%; SEVO-II, 33 ± 4%; SEVO-III, 11 ± 5%; SEVO-VI, 16 ± 4%; all P < 0.001 vs. control, 67 ± 3%) and was least after three and six cycles of sevoflurane (P < 0.001 vs. SEVO-II and -I, respectively). Aprotinin alone had no effect on infarct size but blocked SevoPC. N-nitro-l-arginine-methyl-ester abolished SevoPC (67 ± 4%; P < 0.05 vs. SEVO-III). Aminoguanidine and 7-nitroindazole blocked SevoPC only partially (25 ± 6 and 31 ± 6%, respectively; P < 0.05 vs. SEVO-III and control). SevoPC induced endothelial NOS phosphorylation, which was abrogated by aprotinin.
Conclusion: SevoPC is strengthened by multiple preconditioning cycles, and phosphorylation of endothelial NOS is a crucial step in mediating SevoPC. These effects are abolished by aprotinin.
Similar articles
-
Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.Shock. 2012 May;37(5):485-91. doi: 10.1097/SHK.0b013e318249b7b6. Shock. 2012. PMID: 22266969
-
Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.Life Sci. 2004 Dec 24;76(6):651-60. doi: 10.1016/j.lfs.2004.05.025. Life Sci. 2004. PMID: 15567190
-
Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway.Exp Biol Med (Maywood). 2011 Dec;236(12):1427-36. doi: 10.1258/ebm.2011.011165. Epub 2011 Nov 10. Exp Biol Med (Maywood). 2011. PMID: 22075552
-
Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.Clin Exp Pharmacol Physiol. 2008 Sep;35(9):1043-51. doi: 10.1111/j.1440-1681.2008.04952.x. Epub 2008 May 25. Clin Exp Pharmacol Physiol. 2008. PMID: 18505453
-
[INVOLVEMENT OF NITRIC OXIDE CYNTHASE IN THE EARLY PHASE OF THE HEART ISCHEMIC PRECONDITIONING].Ross Fiziol Zh Im I M Sechenova. 2016 Jul;102(7):792-806. Ross Fiziol Zh Im I M Sechenova. 2016. PMID: 30193047 Review. Russian.
Cited by
-
Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside.Anesth Analg. 2018 Feb;126(2):384-386. doi: 10.1213/ANE.0000000000002690. Anesth Analg. 2018. PMID: 29346202 Free PMC article. No abstract available.
-
Protective effect of sevoflurane on myocardial ischemia-reperfusion injury: a systematic review and meta-analysis.Int J Surg. 2024 Nov 1;110(11):7311-7330. doi: 10.1097/JS9.0000000000001975. Int J Surg. 2024. PMID: 39093878 Free PMC article.
-
Activation of prosurvival signaling pathways during the memory phase of volatile anesthetic preconditioning in human myocardium: a pilot study.Mol Cell Biochem. 2014 Mar;388(1-2):195-201. doi: 10.1007/s11010-013-1910-5. Epub 2013 Nov 26. Mol Cell Biochem. 2014. PMID: 24276754
-
Perioperative cardioprotection.F1000Prime Rep. 2013;5:7. doi: 10.12703/P5-7. Epub 2013 Mar 4. F1000Prime Rep. 2013. PMID: 23513179 Free PMC article.
-
Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway.PeerJ. 2017 Apr 4;5:e3196. doi: 10.7717/peerj.3196. eCollection 2017. PeerJ. 2017. PMID: 28392989 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical